Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386906 · ClinicalTrials.gov registry record · Phase 1
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT00386906: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT00386906 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00386906, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find the sentinel lymph node (SLN) (s) and biopsy it (them) to see if the patient has small or low volume metastatic disease that would otherwise have been missed.
Interventions
- PROCEDURE Sentinel Lymph Node Mapping and Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2000-05-30 |
| Est. Completion | 2023-09-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00386906
The ClinicalTrials.gov registry entry for NCT00386906 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sentinel Lymph Node Mapping and Biopsy is the first listed.
NCT00386906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00386906 about?
NCT00386906 is a clinical study titled "Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma". The goal of this clinical research study is to find the sentinel lymph node (SLN) (s) and biopsy it (them) to see if the patient has small or low volume metastatic disease that would otherwise have been missed.
What is the current status of trial NCT00386906?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2000-05-30. Estimated completion is 2023-09-28.
What interventions are being tested in trial NCT00386906?
The interventions under investigation include: Sentinel Lymph Node Mapping and Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00386906?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.